Chi Michael Buys 13,650 HIMS Shares at $5.01/Share on July 23, 2025.

Hims & Hers Health, Inc. (HIMS) has announced that Chi Michael, the company's Chief Commercial Officer, made several transactions on July 23 and July 24, 2025. Specifically, Michael purchased 12,600 shares at $5.01 per share on July 23, as well as 900 shares at $6.82 per share on the same day. Additionally, he acquired 250 shares at $11.53 per share on July 23. On July 24, Michael sold 13,750 shares at $56 per share, and also purchased 2,100 shares at $5.01 per share, which he subsequently sold at $57.52 per share.

Hims & Hers Health, Inc. (HIMS) has seen a flurry of insider trading activity recently, with Chief Commercial Officer Michael Chi engaging in several transactions on July 23 and July 24, 2025. On July 23, Chi purchased 12,600 shares at $5.01 per share, 900 shares at $6.82 per share, and 250 shares at $11.53 per share. On July 24, he sold 13,750 shares at $56 per share and subsequently purchased 2,100 shares at $5.01 per share, which he sold at $57.52 per share [1].

These transactions come at a critical time for Hims & Hers Health. The company reported a significant 110.7% increase in revenue year-over-year, with earnings per share (EPS) hitting $0.20, surpassing analyst expectations [1]. Despite this positive financial performance, the stock has faced volatility, with a recent 0.3% increase to $57.50 following a 34.6% drop on June 23, 2025, when Novo Nordisk announced the termination of its partnership with Hims & Hers Health [2].

Analyst ratings for HIMS have been mixed, with a consensus rating of "Hold" and a consensus target price of $39.83 [1]. Several institutional investors have recently increased their stakes in the company, with Webster Bank N.A. and Parallel Advisors LLC among those adding to their holdings [1].

Investors should closely monitor these developments, as insider trading can often provide insights into a company's future prospects. However, it is essential to consider the broader context, including the company's financial performance and market conditions, when making investment decisions.

References:
[1] https://www.marketbeat.com/instant-alerts/michael-chi-sells-2100-shares-of-hims-hers-health-inc-nysehims-stock-2025-07-25/
[2] https://www.marketscreener.com/news/hims-hers-health-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-ce7c5fdbdf8ef021